Silvercrest Asset Management Group Inc. (SAMG)

Verve Therapeutics Revenue

Silvercrest Asset Management Group had revenue of $30.67M in the quarter ending June 30, 2025, a decrease of -1.03%. This brings the company's revenue in the last twelve months to $124.45M, up 4.13% year-over-year. In the year 2024, Silvercrest Asset Management Group had annual revenue of $123.65M with 5.32% growth.

• Revenue (ttm): $124.45M
• Revenue Growth: +4.13%
• P/S Ratio: 1.20
• Revenue / Employee: $758,848
• Employees: 164
• Market Cap: 199.44M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	123.65M	6.24M	5.32%
Dec 31, 2023	117.41M	-5.81M	-4.71%
Dec 31, 2022	123.22M	-8.39M	-6.37%
Dec 31, 2021	131.60M	23.62M	21.87%
Dec 31, 2020	107.98M	5.83M	5.71%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.